The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge

Nat Immunol. 2020 Oct;21(10):1146-1151. doi: 10.1038/s41590-020-0779-1.
No abstract available

MeSH terms

  • Angioedema / blood
  • Angioedema / immunology*
  • Angioedema / pathology
  • Angioedema / virology
  • Angiotensin-Converting Enzyme 2
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Antiviral Agents / therapeutic use
  • Betacoronavirus / immunology*
  • Biomarkers / blood
  • COVID-19
  • COVID-19 Drug Treatment
  • COVID-19 Testing
  • Clinical Laboratory Techniques / methods
  • Congresses as Topic
  • Coronavirus Infections / blood
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / immunology*
  • Cytokine Release Syndrome / blood
  • Cytokine Release Syndrome / immunology*
  • Cytokine Release Syndrome / virology
  • Cytokines / antagonists & inhibitors
  • Cytokines / blood
  • Cytokines / immunology
  • Cytokines / metabolism*
  • Humans
  • Internet
  • Kallikrein-Kinin System / drug effects
  • Kallikrein-Kinin System / immunology
  • Pandemics
  • Peptidyl-Dipeptidase A / metabolism
  • Pneumonia, Viral / blood
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / immunology*
  • Pulmonary Alveoli / immunology
  • Pulmonary Alveoli / pathology
  • SARS-CoV-2
  • Severity of Illness Index
  • Signal Transduction / drug effects
  • Signal Transduction / immunology
  • Spike Glycoprotein, Coronavirus / immunology
  • Spike Glycoprotein, Coronavirus / metabolism
  • Time Factors
  • Time-to-Treatment

Substances

  • Anti-Inflammatory Agents
  • Antiviral Agents
  • Biomarkers
  • Cytokines
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • Peptidyl-Dipeptidase A
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2